Lilly Just Placed Million Bet on Injectables Boom
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
We compare value-focused dividend growth ETFs to help you spot the best option based on cost, yield, and growth potential.
27,266 articlesLilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Alibaba is emerging as a potential sleeper AI winner in 2026, trading at a discount while advancing open-source AI an...
XRP on-chain activity climbs to a fresh milestone as big holders stock up, even as the price slips under $1.45. The m...
A billionaire-backed fund is quietly accumulating Robinhood stock even as executives unload shares, a move prompting ...
Investors and policymakers are debating the impact of politicians’ stock holdings as volatility grips markets. Expert...
New high‑voltage lines aimed at powering AI data centers are igniting clashes from rural Pennsylvania to middle Ameri...
Meta forced a mass internal transfer of 1,000 engineers into a new AI unit, signaling a dramatic push into generative...
First-quarter 2026 saw a record pace of home equity withdrawals as borrowers leaned on second liens and HELOCs rather...
As America marks its 250th year, housing policy and loan markets converge to redefine who can own a home and build we...
Berkshire Hathaway disclosed a surprise move this quarter: net selling of big positions and a cash hoard that swelled...
A World Economic Forum analysis shows women’s health receives only 20% of global R&D funding, leaving a $1 trillion o...
Chinese humanoid makers pursue scale and government contracts even as global buyers pull back, creating a rising back...